Prime Medicine, Inc. faces risks in the gene editing sector despite positive developments, caution advised for retail investors. Click for my PRME stock update.

A safety net health care provider has won a $10.3 million interim arbitration judgment against Eagan-based Prime Therapeutics over price-fixing allegations between the local pharmacy benefits manager ...

In a ruling Friday, January 17, Arbitrator Stuart M. Widman found that Prime Therapeutics had violated federal (Sherman Act) and state (Minnesota) antitrust laws in its business dealings with AHF ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

SAN FRANCISCO--(BUSINESS WIRE)--Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation ...

Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardiometabolic diseases ...

Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardiometabolic diseases, ...

SAN FRANCISCO--(BUSINESS WIRE)--Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines ...

(AP Photo/Bilal Hussein) Antoine Shoukeir, the presidency’s director general, announces that Nawaf Salam, a prominent diplomat and jurist is now prime minister-designate at the presidential palace in ...

Lisa Ricciardi, president and CEO of Cognition Therapeutics (NASDAQ: CGTX) was recently a guest on Benzinga’s All-Access. Cognition Therapeutics is a neuroscience company that is developing oral ...